OBJECTIVE: To observe the changes of intestinal inflammation on PDIA3 gene knockout IBS rats and its effect on immune function. METHODS: 36 SD rats were randomly divided into four groups: the control group (n = 8); IBS- empty virus group (IBS-GFP, which); IBS-PDIA3 knockout group (n = 12); IBS- the control group (n = 12). After modeling, colon and ileocecal tissue pathology in each group were observed separately. Changes of immune and inflammatory markers were measured. At the same time, ultrastructural changes in each group were observed by electron microscopy. RESULTS: Compared with the IBS control group, inflammation was reduced significantly in IBS-PDIA3 knockout group. IgE, IL-4 and IL-9 and the level of intestinal trypsin type were decreased significantly. Furthermore, mast cell degranulation and PAR 2 receptor reduced significantly. CONCLUSION: PDIA3 may play an important role in the development of IBS by mediating through immune responses of mucosal abnormalities. However, the mechanism needs to be confirmed in further study.
OBJECTIVE: To observe the changes of intestinal inflammation on PDIA3 gene knockout IBS rats and its effect on immune function. METHODS: 36 SD rats were randomly divided into four groups: the control group (n = 8); IBS- empty virus group (IBS-GFP, which); IBS-PDIA3 knockout group (n = 12); IBS- the control group (n = 12). After modeling, colon and ileocecal tissue pathology in each group were observed separately. Changes of immune and inflammatory markers were measured. At the same time, ultrastructural changes in each group were observed by electron microscopy. RESULTS: Compared with the IBS control group, inflammation was reduced significantly in IBS-PDIA3 knockout group. IgE, IL-4 and IL-9 and the level of intestinal trypsin type were decreased significantly. Furthermore, mast cell degranulation and PAR 2 receptor reduced significantly. CONCLUSION:PDIA3 may play an important role in the development of IBS by mediating through immune responses of mucosal abnormalities. However, the mechanism needs to be confirmed in further study.
Authors: Tobias Liebregts; Birgit Adam; Christoph Bredack; Alexander Röth; Susanne Heinzel; Sue Lester; Sarah Downie-Doyle; Eric Smith; Paul Drew; Nicholas J Talley; Gerald Holtmann Journal: Gastroenterology Date: 2007-01-26 Impact factor: 22.682
Authors: Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle Journal: J Clin Invest Date: 2007-02-15 Impact factor: 14.808
Authors: Cesare Cremon; Luciana Gargano; Antonio M Morselli-Labate; Donatella Santini; Rosanna F Cogliandro; Roberto De Giorgio; Vincenzo Stanghellini; Roberto Corinaldesi; Giovanni Barbara Journal: Am J Gastroenterol Date: 2009-01-13 Impact factor: 10.864
Authors: Masaki Kashiwada; Deborah M Levy; Lisa McKeag; Keri Murray; Andreas J Schröder; Stephen M Canfield; Geri Traver; Paul B Rothman Journal: Proc Natl Acad Sci U S A Date: 2009-12-22 Impact factor: 11.205
Authors: Jeroen Aerssens; Michael Camilleri; Willem Talloen; Leen Thielemans; Hinrich W H Göhlmann; Ilse Van Den Wyngaert; Theo Thielemans; Ronald De Hoogt; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Busciglio; Duane D Burton; Thomas Smyrk; Raul Urrutia; Bernard Coulie Journal: Clin Gastroenterol Hepatol Date: 2008-02 Impact factor: 11.382
Authors: Antony N Antoniou; Susana G Santos; Elaine C Campbell; Sarah Lynch; Fernando A Arosa; Simon J Powis Journal: FEBS Lett Date: 2007-04-24 Impact factor: 4.124
Authors: Yongsheng Li; Brandon Burgman; Daniel J McGrail; Ming Sun; Dan Qi; Sachet A Shukla; Erxi Wu; Anna Capasso; Shiaw-Yih Lin; Catherine J Wu; S Gail Eckhardt; Gordon B Mills; Bo Li; Nidhi Sahni; S Stephen Yi Journal: Cancer Res Date: 2020-08-27 Impact factor: 12.701